Literature DB >> 28781674

MicroRNA-433 regulates apoptosis by targeting PDCD4 in human osteosarcoma cells.

Yinghua Sun1, Fuchao Wang1, Li Wang1, Zhaode Jiao1, Jun Fang1, Jianmin Li2.   

Abstract

Osteosarcoma is the most common aggressive sarcoma of the bone in children and adolescents. It is characterized by a high level of genetic instability and recurrent DNA deletions and amplifications. microRNAs (miRNAs) play a key role in cancer initiation, progression and metastasis; however, the potential role of miRNAs in osteosarcoma remains largely unknown. In the present study, miR-433 was shown to be overexpressed in osteosarcoma tissues compared with normal human osteoblasts. Transfection of miR-433 mimics into osteosarcoma cell lines significantly decreased apoptosis by targeting programmed cell death 4, a tumor suppressor that is involved in apoptosis. In contrast, inhibition of miR-433 enhanced apoptosis. Furthermore, in vivo miR-433 overexpression inhibited the apoptosis of tumor cells and increased tumor growth. The results of the present study suggested that miR-433 is a potential molecular target for osteosarcoma therapy.

Entities:  

Keywords:  apoptosis; miR-433; osteosarcoma; programmed cell death 4

Year:  2017        PMID: 28781674      PMCID: PMC5530199          DOI: 10.3892/ol.2017.6441

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.

Authors:  X Lin; K L Rice; M Buzzai; E Hexner; F F Costa; O Kilpivaara; A Mullally; M B Soares; B L Ebert; R Levine; J D Licht
Journal:  Leukemia       Date:  2012-08-06       Impact factor: 11.528

3.  Efficient multi-site-directed mutagenesis directly from genomic template.

Authors:  Fengtao Luo; Xiaolan Du; Tujun Weng; Xuan Wen; Junlan Huang; Lin Chen
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

4.  microRNA regulation in cancer: One arm or two arms?

Authors:  Ramkrishna Mitra; Jingchun Sun; Zhongming Zhao
Journal:  Int J Cancer       Date:  2015-04-20       Impact factor: 7.396

Review 5.  Current treatment of osteosarcoma.

Authors:  W S Ferguson; A M Goorin
Journal:  Cancer Invest       Date:  2001       Impact factor: 2.176

6.  miR-34a inhibits the metastasis of osteosarcoma cells by repressing the expression of CD44.

Authors:  Haien Zhao; Baoan Ma; Yucai Wang; Tao Han; Lianhe Zheng; Cong Sun; Tao Liu; Yinglong Zhang; Xiuchun Qiu; Qingyu Fan
Journal:  Oncol Rep       Date:  2013-01-11       Impact factor: 3.906

7.  Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.

Authors:  A H Aljubran; A Griffin; M Pintilie; M Blackstein
Journal:  Ann Oncol       Date:  2009-01-19       Impact factor: 32.976

8.  Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

Authors:  Karolina Weiner-Gorzel; Eugene Dempsey; Malgorzata Milewska; Aloysius McGoldrick; Valerie Toh; Aoibheann Walsh; Sinead Lindsay; Luke Gubbins; Aoife Cannon; Daniel Sharpe; Jacintha O'Sullivan; Madeline Murphy; Stephen F Madden; Malcolm Kell; Amanda McCann; Fiona Furlong
Journal:  Cancer Med       Date:  2015-02-15       Impact factor: 4.452

9.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.

Authors:  Qiang Wang; Jun Cai; Jingcheng Wang; Chuanzhi Xiong; Jianning Zhao
Journal:  Tumour Biol       Date:  2014-09-17

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  5 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

2.  Analysis of Circulating miRNA Profile in Plasma Samples of Glioblastoma Patients.

Authors:  Dóra Géczi; Bálint Nagy; Melinda Szilágyi; András Penyige; Álmos Klekner; Adrienn Jenei; József Virga; Zsuzsanna Birkó
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

3.  Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis.

Authors:  Lin Xie; Zhihong Yao; Ya Zhang; Dongqi Li; Fengdi Hu; Yedan Liao; Ling Zhou; Yonghong Zhou; Zeyong Huang; Zewei He; Lei Han; Yihao Yang; Zuozhang Yang
Journal:  Cell Death Dis       Date:  2018-07-10       Impact factor: 8.469

Review 4.  The Regulatory Role of Non-coding RNAs on Programmed Cell Death Four in Inflammation and Cancer.

Authors:  Mengxiang Zhao; Nisha Zhu; Fengyao Hao; Yuxian Song; Zhiyong Wang; Yanhong Ni; Liang Ding
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244

5.  Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma.

Authors:  Xuesen Li; Na Li; Qinghui Niu; Haibin Zhu; Zhijie Wang; Qingxian Hou
Journal:  Onco Targets Ther       Date:  2020-03-02       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.